Abrams J J, Grundy S M, Ginsberg H
J Lipid Res. 1981 Feb;22(2):307-22.
Studies on plasma triglycerides (TG) were performed in 10 nonobese and 16 obese patients with hypothyroidism and in 13 with hyperthyroidism. Nonobese, hypothyroid patients generally had normal levels of TG, but obese patients often had hypertriglyceridemia. In most hypothyroid patients 1-thyroxine treatment lowered plasma TG, and most hyperthyroid patients had low TG. One mechanism whereby thyroid hormones might decrease plasma TG could be to increase lipoprotein lipase (LPL). However, post-heparin LPL was not increased after therapy, nor was it increased in hyperthyroid patients. In contrast, hypothyroid patients had abnormally low levels of post-heparin hepatic triglyceride lipase. In hypothyroid patients without hypertriglyceridemia, clearance of chylomicrons was normal. A few obese, hypothyroid patients with fasting hypertriglyceridemia had low clearance of chylomicrons, which may have been due in part to competition for removal of excess endogenous TG. Thus, no evidence was obtained for a significant abnormality in chylomicron metabolism in hypothyroidism. Nonobese, hypothyroid patients had normal synthesis and clearance of very low density lipoprotein (VLDL)-TG. In contrast, VLDL-TG synthesis was increased in 8 obese, hypothyroid patients, and fractional clearance rates were relatively low compared to obese, euthyroid subjects. In striking contrast, hyperthyroid patients had remarkable facility in clearing VLDL-TG. Thus, TG metabolism is not grossly deranged in hypothyroidism, but thyroid hormones apparently can promote catabolism of VLDL.
对10名非肥胖和16名肥胖的甲状腺功能减退患者以及13名甲状腺功能亢进患者进行了血浆甘油三酯(TG)研究。非肥胖的甲状腺功能减退患者的TG水平通常正常,但肥胖患者常出现高甘油三酯血症。在大多数甲状腺功能减退患者中,左旋甲状腺素治疗可降低血浆TG,而大多数甲状腺功能亢进患者的TG水平较低。甲状腺激素降低血浆TG的一种机制可能是增加脂蛋白脂肪酶(LPL)。然而,治疗后肝素后LPL并未增加,甲状腺功能亢进患者也未增加。相反,甲状腺功能减退患者的肝素后肝甘油三酯脂肪酶水平异常低。在没有高甘油三酯血症的甲状腺功能减退患者中,乳糜微粒的清除是正常的。少数患有空腹高甘油三酯血症的肥胖甲状腺功能减退患者乳糜微粒清除率较低,这可能部分是由于竞争去除过量的内源性TG。因此,未获得甲状腺功能减退患者乳糜微粒代谢存在明显异常的证据。非肥胖的甲状腺功能减退患者极低密度脂蛋白(VLDL)-TG的合成和清除正常。相比之下,8名肥胖的甲状腺功能减退患者的VLDL-TG合成增加,与肥胖的甲状腺功能正常受试者相比,分数清除率相对较低。与之形成鲜明对比的是,甲状腺功能亢进患者在清除VLDL-TG方面具有显著能力。因此,甲状腺功能减退时TG代谢并未严重紊乱,但甲状腺激素显然可以促进VLDL的分解代谢。